Effect of adalimumab on extraintestinal manifestations among patients with ulcerative colitis in a clinical practice setting: results from INSPIRADA

Effect of adalimumab on extraintestinal manifestations among patients with ulcerative colitis in a clinical practice setting: results from INSPIRADA

Extraintestinal manifestations (EIMs) are common in patients with ulcerative colitis (UC) and can have a significant impact on patient morbidity and quality of life. We assessed the effect of adalimumab (ADA) therapy on the resolution of EIMs among patients with moderate to severe UC in clinical pra...

Бүрэн тодорхойлолт

Номзүйн дэлгэрэнгүй
Үндсэн зохиолчид:	Travis, S, Feagan, B, Peyrin-Biroulet, L, Panaccione, R, Danese, S, Lazar, A, Robinson, A, Thakkar, R, Pappalardo, B, Petersson, J, Bereswill, M, Chen, N, Skup, M
Формат:	Journal article
Хэвлэсэн:	Oxford University Press 2017

Ижил төстэй зүйлс

Effect of adalimumab dose escalation on clinical, health-related quality of life, treatment satisfaction and work productivity outcomes among patients with ulcerative colitis in a clinical practice setting: results from INSPIRADA
-н: Travis, S, зэрэг
Хэвлэсэн: (2017)

Effect of adalimumab on clinical outcomes and health-related quality of life among patients with ulcerative colitis in a clinical practice setting: Results from inspirADA
-н: Travis, S, зэрэг
Хэвлэсэн: (2017)

Effect of adalimumab on clinical outcomes and health-related quality of life among patients with ulcerative colitis in a clinical practice setting: Results From InspirADA.
-н: Travis, S, зэрэг
Хэвлэсэн: (2017)

The Crohn's disease–ulcerative colitis clinical appraisal update: emerging trends in clinical practice
-н: Sandborn, W, зэрэг
Хэвлэсэн: (2016)

Does it all ADA up? Adalimumab for ulcerative colitis.
-н: Travis, S
Хэвлэсэн: (2011)

Should extraintestinal manifestations (EIMs) be part of disease activity assessment in ulcerative colitis?
-н: Walsh, A, зэрэг
Хэвлэсэн: (2018)

Evaluating Upadacitinib in the Treatment of Moderate-to-Severe Active Ulcerative Colitis: Design, Development, and Potential Position in Therapy
-н: Napolitano M, зэрэг
Хэвлэсэн: (2022-06-01)

Immune Thrombocytopenic Purpura as an Extraintestinal Manifestation in a Patient with Ulcerative Colitis
-н: Renata de Medeiros Dutra, зэрэг
Хэвлэсэн: (2022-03-01)

Extraintestinal manifestations at baseline, and the effect of tofacitinib, in patients with moderate to severe ulcerative colitis
-н: David T. Rubin, зэрэг
Хэвлэсэн: (2021-05-01)

Raising the bar in ulcerative colitis management
-н: Fabrizio Fanizzi, зэрэг
Хэвлэсэн: (2024-11-01)

Pulmonary Extraintestinal Manifestation of Crohn’s Disease Treated Successfully with Adalimumab
-н: Dongyeol Shin, зэрэг
Хэвлэсэн: (2018-09-01)

Tofacitinib in the treatment of ulcerative colitis: efficacy and safety from clinical trials to real-world experience
-н: Ferdinando D’Amico, зэрэг
Хэвлэсэн: (2019-05-01)

A Case of Syrian Child with Cerebral Infarction as an Extraintestinal Manifestation of Ulcerative Colitis
-н: Riham Salloum, зэрэг
Хэвлэсэн: (2019-01-01)

Increased Demand for Therapeutic Drugs in Pediatric Ulcerative Colitis Patients With Extraintestinal Manifestations
-н: Yiyoung Kwon, зэрэг
Хэвлэсэн: (2022-05-01)

Meta‐analysis of the association of extraintestinal manifestations with the development of pouchitis in patients with ulcerative colitis
-н: K. Hata, зэрэг
Хэвлэсэн: (2019-08-01)

Role of Probiotics in the Management of Patients with Ulcerative Colitis and Pouchitis
-н: Francesca Bernardi, зэрэг
Хэвлэсэн: (2024-12-01)

Multiple extraintestinal manifestations in a patient with acute severe ulcerative colitis: a case report
-н: Eun Young Park, зэрэг
Хэвлэсэн: (2022-12-01)

Factors Associated with the Presence of Extraintestinal Manifestations in Patients with Ulcerative Colitis in a Latin American Country
-н: Jesús K. Yamamoto-Furusho, зэрэг
Хэвлэсэн: (2020-10-01)

Infliximab versus Adalimumab, Which One Is Better for Ulcerative Colitis?
-н: Eun Soo Kim
Хэвлэсэн: (2021-03-01)

Febrile neutropenia associated with adalimumab in a patient with ulcerative colitis
-н: Ma’In Atallah Mohammad Abumuhfouz, зэрэг
Хэвлэсэн: (2024-04-01)

Albumin change predicts failure in ulcerative colitis treated with adalimumab
-н: Natsuki Ishida, зэрэг
Хэвлэсэн: (2024-01-01)

Adalimumab-associated bullous pemphigoid in a patient with ulcerative colitis
-н: Laurel L. Wessman, BS, зэрэг
Хэвлэсэн: (2017-07-01)

Cost-utility analysis of infliximab and adalimumab for refractory ulcerative colitis
-н: Assasi Nazila, зэрэг
Хэвлэсэн: (2009-12-01)

Management of difficult-to-treat patients with ulcerative colitis: focus on adalimumab
-н: Armuzzi A, зэрэг
Хэвлэсэн: (2013-04-01)

Developments in the treatment of moderate to severe ulcerative colitis: focus on adalimumab
-н: Freeman HJ
Хэвлэсэн: (2013-11-01)

Real-World Maintenance Phase Persistence on Ustekinumab and Adalimumab in Ulcerative Colitis
-н: Zhdanava M, зэрэг
Хэвлэсэн: (2024-04-01)

Defining endoscopic response and remission in ulcerative colitis clinical trials: an international consensus
-н: Vuitton, L, зэрэг
Хэвлэсэн: (2017)

Understanding the Role of Adalimumab in the Treatment of Moderately to Severely Active Ulcerative Colitis
Хэвлэсэн: (2016-03-01)

Bullous Pemphigoid Associated with Adalimumab Therapy in a Patient with Ulcerative Colitis
-н: Sebastian Hoffmann, зэрэг
Хэвлэсэн: (2018-05-01)

ADALIMUMAB FOR ULCERATIVE COLITIS: RESULTS OF A BRAZILIAN MULTICENTER OBSERVATIONAL STUDY
-н: Patrícia ZACHARIAS, зэрэг
Хэвлэсэн: (2017-10-01)

Leukocytoclastic Vasculitis as a Rare Dermatologic Extraintestinal Manifestation of Ulcerative Colitis in an Elderly Patient with Positive PR3-ANCA
-н: Jacky Ng, зэрэг
Хэвлэсэн: (2021-01-01)

Exploring genetic associations of Crohn’s disease and ulcerative colitis with extraintestinal cancers in European and East Asian populations
-н: Chengdong Yu, зэрэг
Хэвлэсэн: (2024-02-01)

Steroid-refractory extensive enteritis complicated by ulcerative colitis successfully treated with adalimumab
-н: Shinji Okabayashi, зэрэг
Хэвлэсэн: (2017-10-01)

Comparison of long-term outcomes of infliximab and adalimumab therapy in biologic-naive patients with ulcerative colitis
-н: Muhammed B. Durak, зэрэг
Хэвлэсэн: (2025-01-01)

International Consensus on Definition of Mild-to-Moderate Ulcerative Colitis Disease Activity in Adult Patients
-н: Bénédicte Caron, зэрэг
Хэвлэсэн: (2023-01-01)

Developing an instrument to assess the endoscopic severity of ulcerative colitis: the Ulcerative Colitis Endoscopic Index of Severity (UCEIS).
-н: Travis, S, зэрэг
Хэвлэсэн: (2012)

Henoch-Schönlein Purpura with Adalimumab Therapy for Ulcerative Colitis: A Case Report and Review of the Literature
-н: Joseph J. LaConti, зэрэг
Хэвлэсэн: (2016-01-01)

Effectiveness of adalimumab in severe ulcerative colitis: A systematic review and a meta‐analysis
-н: Saleh Azadbakht, зэрэг
Хэвлэсэн: (2024-07-01)

Real-Life Treatment Paradigms Show Adalimumab Is Cost-Effective for the Management of Ulcerative Colitis
-н: Candace L. Beilman, зэрэг
Хэвлэсэн: (2016-01-01)

Adalimumab biosimilars in the therapy of Crohn´s disease and ulcerative colitis: Prospective multicentric clinical monitoring.
-н: Martin Wasserbauer, зэрэг
Хэвлэсэн: (2022-01-01)